Suhaila O. Suliman is a graduate student in the Ph.D. program in Pharmaceutics at the University of Iowa. As part of her Ph.D. studies, she focuses on enhancing cancer vaccine efficacy and stimulating robust tumor-specific immune responses using particle-based formulations. She is also interested in studying biodistribution and pharmacokinetics of